Showing 1 - 5 results of 5 for search 'Seyed Reza Mousavi (13223324)', सवाल का समय: 0.01सेकंड परिणाम को परिष्कृत करें
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. द्वारा Seyed Reza Mousavi (13223324)

    प्रकाशित 2025
    सूची में सहेजें
    में बचाया:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. द्वारा Seyed Reza Mousavi (13223324)

    प्रकाशित 2025
    सूची में सहेजें
    में बचाया:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. द्वारा Seyed Reza Mousavi (13223324)

    प्रकाशित 2025
    सूची में सहेजें
    में बचाया:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. द्वारा Seyed Reza Mousavi (13223324)

    प्रकाशित 2025
    सूची में सहेजें
    में बचाया:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. द्वारा Seyed Reza Mousavi (13223324)

    प्रकाशित 2025
    सूची में सहेजें
    में बचाया:

खोज साधन: